Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120–CD4-binding site from long-term survivors of HIV infection

(2010) Stephanie Planque et al.   AIDS

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

(2010) M. Lobigs et al.   JOURNAL OF GENERAL VIROLOGY

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

(2009) Gary R Matyas et al.   AIDS

Mucosal Vaccine Using CTL Epitope-Pulsed Dendritic Cell Confers Protection for Intracellular Pathogen

(2009) Yuichi Ozawa et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination

(2009) F Barone et al.   Mucosal Immunology

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination

(2009) M Manrique et al.   Mucosal Immunology

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

(2009) Scott G Hansen et al.   NATURE MEDICINE

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

(2009) Y. Guan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel humanized murine models for HIV research

(2009) Paul W. Denton et al.   Current HIV/AIDS Reports

DNA-MVA Vaccine Protection after X4 SHIV Challenge in Macaques Correlates with Day-of-Challenge Antiviral CD4+ Cell-Mediated Immunity Levels and Postchallenge Preservation of CD4+ T Cell Memory

(2008) Mariana Manrique et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat

(2008) Anthony D. Cristillo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Freeing vaccine adjuvants from dangerous immunological dogma

(2008) Nikolai Petrovsky   Expert Review of Vaccines

Toll-Like Receptor Signaling in Small Intestinal Epithelium Promotes B-Cell Recruitment and IgA Production in Lamina Propria

(2008) Limin Shang et al.   GASTROENTEROLOGY

Failure of the Merck HIV vaccine: an uncertain step forward

(2008) Merlin L Robb   LANCET

Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses

(2008) H Kamijuku et al.   Mucosal Immunology

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

(2008) David I Watkins et al.   NATURE MEDICINE

Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity

(2008) Robin J Shattock et al.   PLOS MEDICINE

Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation

(2007) Anthony D. Cristillo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery

(2007) Amanda Goodsell et al.   IMMUNOLOGY